MetaADEDB 2.0 @ LMMD
Emtricitabine
(XQSPYNMVSIKCOC-NTSWFWBYSA-N)
Structure
SMILES
Nc1nc(=O)n(cc1F)[C@@H]1CS[C@@H](O1)CO
Type(s)
Approved; Investigational
ATC code(s)
J05AF09; J05AR03; J05AR06; J05AR08; J05AR09; J05AR17; J05AR18; J05AR19; J05AR20; J05AR22
Molecular Formula:
C8H10FN3O3S
Molecular Weight:
247.247
Log P:
0.1262
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
115.67
CAS Number(s):
143491-54-7; 143491-57-0; 145213-48-5
Synonym(s)
1.
Emtricitabine
2.
Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
3.
Coviracil
4.
Emtriva
5.
Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
External Link(s)
MeSHD000068679
PubChem Compound60877
BindingDB50107843
ChEBI31536
CHEMBLCHEMBL885
DrugBankDB00879
DrugCentral1003
KEGGcpd:C12599
dr:D01199
Therapeutic Target DatabaseD0S9SD
ZINC3629271
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Accidental overdoseFAERS: 2US FAERS
2Acquired gene mutationFAERS: 2US FAERS
3Medication ErrorFAERS: 2US FAERS
4treatment failureFAERS: 2US FAERS
5Blood creatinine increasedFAERS: 1SIDER
US FAERS
6Cerebrovascular accidentFAERS: 1US FAERS
7Drug ineffectiveFAERS: 1US FAERS
8Genotype drug resistance test positiveFAERS: 1US FAERS
9Product dispensing errorFAERS: 1US FAERS
10Product storage errorFAERS: 1US FAERS
11Stevens-Johnson SyndromeFAERS: 1US FAERS
12Viral mutation identifiedFAERS: 1US FAERS
13Abdominal PainSIDER
14Alanine Aminotransferase IncreasedSIDER
15Amylase increasedSIDER
16AngioedemaSIDER
17AnxietySIDER
18ArthralgiaSIDER
19AstheniaSIDER
20Back PainSIDER
21Blood and lymphatic system disordersSIDER
22Blood creatine phosphokinase increasedSIDER
23Blood glucose decreasedSIDER
24Blood triglycerides increasedSIDER
25Bone painSIDER
26Buffalo humpSIDER
27Creatine Phosphokinase IncreasedSIDER
28Creatinine increasedSIDER
29Depressive disorderSIDER
30DermatitisSIDER
31DizzinessSIDER
32DyspepsiaSIDER
33Dysthymic DisorderSIDER
34Exfoliative rashSIDER
35Fanconi SyndromeSIDER
36FastingSIDER
37FatigueSIDER
38FractureSIDER
39GastroenteritisSIDER
40Gastrointestinal PainSIDER
41Glucose lowSIDER
42GlycosuriaSIDER
43HIV Infections

View details

17530837
18361857
19542866
20032539
23548184
 		CTD
44HeadacheSIDER
45Hepatitis B

View details

1336341
10418752
15388423
16152756
17099372
19584701
 		CTD
SIDER
46HepatitisSIDER
47HepatomegalySIDER
48HypersensitivitySIDER
49Hypertrophy of BreastSIDER
50InfectionSIDER
51InfestationSIDER
52InflammationSIDER
53Insulin ResistanceSIDER
54Lipase increasedSIDER
55Lipodystrophy acquiredSIDER
56LipodystrophySIDER
57LipohypertrophySIDER
58MalnutritionSIDER
59Musculoskeletal discomfortSIDER
60MyalgiaSIDER
61MyopathySIDER
62NasopharyngitisSIDER
63NauseaSIDER
64Nephrogenic Diabetes InsipidusSIDER
65NeuritisSIDER
66NeuropathySIDER
67NeutropeniaSIDER
68OsteomalaciaSIDER
69Otitis MediaSIDER
70PainSIDER
71PancreatitisSIDER
72PharyngitisSIDER
73PneumoniaSIDER
74PolyuriaSIDER
75Protein urine presentSIDER
76ProteinuriaSIDER
77PrurigoSIDER
78PruritusSIDER
79Renal tubular disorderSIDER
80Renal tubular necrosisSIDER
81RhabdomyolysisSIDER
82RhinitisSIDER
83SinusitisSIDER
84Syncope18361857CTD
85SyphilisSIDER
86ThrombocytopeniaSIDER
87Urethritis noninfectiveSIDER
88UrethritisSIDER
89Urinary tract infectionSIDER
90Urine output increasedSIDER
91UrticariaSIDER
92Vesiculobullous rashSIDER
93VomitingSIDER
94Weight decreasedSIDER
95nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.